| Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens (NCT01428973) | University of Liege | 2011-09-01 |
| Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT) (NCT01379209) | Regimmune Corporation | 2011-09-01 |
| T&B Depletion Non Malignant (NCT01810926) | Franco Locatelli | 2011-09-01 |
| In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus (NCT01453140) | Hackensack Meridian Health | 2011-08-01 |
| Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease (NCT01522716) | Karolinska Institutet | 2011-08-01 |
| The Natural History of Graft-Versus-Host Disease in the Eyes (NCT01369914) | National Eye Institute (NEI) | 2011-05-20 |
| Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease (NCT01309997) | Lee, Stephanie | 2011-03-01 |
| Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression (NCT02178683) | Colorado Blood Cancer Institute | 2010-11-01 |
| Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer (NCT01233921) | Martin, Paul | 2010-09-01 |
| Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy. (NCT01174277) | University of Kansas Medical Center | 2010-08-01 |
| Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation (NCT01116232) | Barbara Ann Karmanos Cancer Institute | 2010-08-01 |
| Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention (NCT01487577) | University of Pittsburgh | 2010-06-01 |
| Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease. (NCT01222039) | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 2010-06-01 |
| Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD) (NCT01135641) | Nantes University Hospital | 2010-06-01 |
| A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD) (NCT01066598) | University Health Network, Toronto | 2010-05-01 |
| Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD) (NCT01111526) | H. Lee Moffitt Cancer Center and Research Institute | 2010-04-01 |
| Acute Graft-versus-Host Disease Treatment (BMT CTN 0802) (NCT01002742) | Medical College of Wisconsin | 2010-01-01 |
| Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD (NCT00914940) | Fred Hutchinson Cancer Center | 2009-12-17 |
| Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer (NCT01044745) | University of Nebraska | 2009-12-10 |
| Allogeneic Mesenchymal Stem Cell for Graft-Versus-Host Disease Treatment (NCT00749164) | Hadassah Medical Organization | 2009-09-01 |
| T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant (NCT00986557) | University Hospital Birmingham | 2009-09-01 |
| Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease (NCT00972660) | Guangdong Provincial People's Hospital | 2009-09-01 |
| Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults (NCT00912067) | Sheba Medical Center | 2009-07-01 |
| Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease (NCT00929695) | Fred Hutchinson Cancer Center | 2009-06-01 |
| Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD (NCT00524784) | Hadassah Medical Organization | 2009-06-01 |
| Extracorporeal Photopheresis in Children and Young Adults With Refractory Acute Graft Versus Host Disease (NCT00824954) | University Hospital, Clermont-Ferrand | 2009-06-01 |
| Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation (NCT00948753) | Abramson Cancer Center at Penn Medicine | 2009-06-01 |
| Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant (NCT00639717) | University of Michigan Rogel Cancer Center | 2009-03-01 |
| Exploratory Study of Natural Killer Cells in Human Skin (NCT00824889) | Assistance Publique Hopitaux De Marseille | 2009-02-01 |
| Treatment of Steroid Resistant GVHD by Infusion MSC (NCT00827398) | N.M. Wulffraat | 2009-01-01 |
| Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease (NCT00792246) | Phillip Brian Smith | 2008-12-01 |
| Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder (NCT00755040) | Vanderbilt-Ingram Cancer Center | 2008-10-01 |
| Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants (NCT00775632) | University Health Network, Toronto | 2008-10-01 |
| Natural History and Pathophysiology of Gastrointestinal Graft-versus-Host Disease (NCT00723593) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2008-07-23 |
| Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity Conditioning (NCT00781781) | CABYC | 2008-07-01 |
| Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant (NCT00725062) | Masonic Cancer Center, University of Minnesota | 2008-06-01 |
| Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases (NCT00813501) | City of Hope Medical Center | 2008-06-01 |
| A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT (NCT00616954) | Hadassah Medical Organization | 2008-05-01 |
| Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD) (NCT00675441) | M.D. Anderson Cancer Center | 2008-04-01 |
| Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer (NCT00923845) | National Cancer Institute (NCI) | 2008-03-01 |
| Rapamycin for Prevention of Chronic Graft-Versus-Host Disease (NCT00623012) | Yale University | 2008-02-01 |
| Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD) (NCT00562497) | Mesoblast, Inc. | 2008-01-31 |
| Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders (NCT00740467) | Institut Paoli-Calmettes | 2008-01-01 |
| Photopheresis for the Treatment of Acute Graft Versus Host Disease (NCT00609609) | M.D. Anderson Cancer Center | 2008-01-01 |
| Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant (NCT00513474) | Massachusetts General Hospital | 2008-01-01 |
| Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function (NCT00603330) | University of Liege | 2008-01-01 |
| Analysis of the Clinical and Histological Correlation of Oral Graft-Versus-Host-Disease (GVHD) (NCT00898885) | University of Sao Paulo | 2008-01-01 |
| Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation (NCT00720629) | H. Lee Moffitt Cancer Center and Research Institute | 2007-12-01 |
| A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan (NCT00577278) | City of Hope Medical Center | 2007-10-03 |
| Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation (NCT01941394) | National Research Center for Hematology, Russia | 2007-10-01 |
| Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00555048) | Fred Hutchinson Cancer Center | 2007-09-01 |
| Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation (NCT00993343) | Karolinska Institutet | 2007-09-01 |
| Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease (NCT00529035) | Dana-Farber Cancer Institute | 2007-08-01 |
| Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer (NCT00589563) | City of Hope Medical Center | 2007-05-01 |
| High-Dose Cyclophosphamide for Steroid Refractory GVHD (NCT00492921) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-05-01 |
| Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases (NCT00376519) | Masonic Cancer Center, University of Minnesota | 2007-05-01 |
| Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00489203) | Fred Hutchinson Cancer Center | 2007-04-01 |
| Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission (NCT00382109) | Children's Oncology Group | 2007-03-01 |
| Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases (NCT00438958) | The Canadian Blood and Marrow Transplant Group | 2007-03-01 |
| Study of Opebacan in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (NCT00454155) | XOMA (US) LLC | 2007-02-01 |
| Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant (NCT00900406) | Vanderbilt-Ingram Cancer Center | 2007-01-01 |
| Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids (NCT00489216) | UNC Lineberger Comprehensive Cancer Center | 2006-12-01 |
| Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases (NCT00450983) | Fred Hutchinson Cancer Center | 2006-12-01 |
| Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease (NCT00423514) | Memorial Sloan Kettering Cancer Center | 2006-11-20 |
| Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease (NCT00373815) | University Hospital Tuebingen | 2006-09-01 |
| Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD) (NCT00366145) | Mesoblast, Inc. | 2006-08-17 |
| Feasibility Study of Collecting Multicenter Chronic GVHD Data (NCT00506233) | M.D. Anderson Cancer Center | 2006-08-01 |
| Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant (NCT00410657) | Fred Hutchinson Cancer Center | 2006-07-01 |
| Alefacept for Prevention of Graft Versus Host Disease (GVHD) (NCT00361413) | Hadassah Medical Organization | 2006-06-01 |
| Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer (NCT00346359) | Fred Hutchinson Cancer Center | 2006-03-01 |
| Experience of Having Chronic Graft-Versus-Host Disease (NCT00353106) | M.D. Anderson Cancer Center | 2006-02-01 |
| Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation (NCT00282282) | Dana-Farber Cancer Institute | 2006-01-01 |
| Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation (NCT00189488) | Swedish Orphan Biovitrum | 2005-12-01 |
| Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Participants (NCT00284986) | Mesoblast, Inc. | 2005-11-18 |
| Study on the Safety and Effectiveness of VELCADE® in the Treatment of Graft-Versus-Host Disease (NCT00408928) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2005-11-01 |
| Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil (NCT00608517) | Vanderbilt-Ingram Cancer Center | 2005-09-01 |
| Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX (NCT00360685) | H. Lee Moffitt Cancer Center and Research Institute | 2005-09-01 |
| Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease (NCT00462657) | St. Bartholomew's Hospital | 2005-07-01 |
| Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer (NCT00611351) | University of Nebraska | 2005-06-07 |
| Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation (NCT00450268) | Technische Universität Dresden | 2005-01-01 |
| Campath-1H + FK506 and Methylprednisolone for GVHD (NCT00109993) | Case Comprehensive Cancer Center | 2005-01-01 |
| A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension- (NCT00189748) | Astellas Pharma Inc | 2004-08-01 |
| Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00096096) | Fred Hutchinson Cancer Center | 2004-08-01 |
| Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT) (NCT00141739) | University of Michigan Rogel Cancer Center | 2004-08-01 |
| Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (NCT00093587) | Jonsson Comprehensive Cancer Center | 2004-08-01 |
| G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders (NCT00253552) | OHSU Knight Cancer Institute | 2004-05-01 |
| Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation (NCT00201799) | Ohio State University Comprehensive Cancer Center | 2004-02-01 |
| Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation (NCT00948727) | Assistance Publique - Hôpitaux de Paris | 2004-01-01 |
| Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation (NCT00180089) | Technische Universität Dresden | 2004-01-01 |
| Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease (NCT00074035) | Alliance for Clinical Trials in Oncology | 2003-12-01 |
| Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis (NCT00075023) | National Institute of Nursing Research (NINR) | 2003-12-01 |
| Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer (NCT00255684) | University of Rochester | 2003-12-01 |
| Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation (NCT00144677) | Dana-Farber Cancer Institute | 2003-11-01 |
| The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease (NCT00141713) | University of Michigan Rogel Cancer Center | 2003-10-01 |
| Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer (NCT00248430) | Fred Hutchinson Cancer Center | 2003-08-01 |
| Extracorporeal Photopheresis for Acute Graft Versus Host Disease (NCT00179855) | Ann & Robert H Lurie Children's Hospital of Chicago | 2003-07-01 |
| Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease (NCT00201786) | Ohio State University Comprehensive Cancer Center | 2003-07-01 |
| Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00089037) | Fred Hutchinson Cancer Center | 2003-06-01 |
| Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies (NCT00943293) | University of Chicago | 2003-05-01 |
| Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant (NCT00096161) | Fred Hutchinson Cancer Center | 2003-05-01 |